References to the "Company," "BCLS Acquisition Corp.," "our," "us" or "we" refer
to BCLS Acquisition Corp. The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with
the unaudited interim condensed financial statements and the notes thereto
contained elsewhere in this Quarterly Report on Form
10-Q.
Certain information contained in the discussion and analysis set forth below
includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
Some of the statements contained in this Quarterly Report on Form
10-Q
may constitute "forward-looking statements" for purposes of the federal
securities laws. Our forward-looking statements include, but are not limited to,
statements regarding our or our management team's expectations, hopes, beliefs,
intentions or strategies regarding the future. In addition, any statements that
refer to projections, forecasts or other characterizations of future events or
circumstances, including any underlying assumptions, are forward-looking
statements. The words "anticipate," "believe," "continue," "could," "estimate,"
"expect," "intend," "may," "might," "plan," "possible," "potential," "predict,"
"project," "should," "would" and similar expressions may identify
forward-looking statements, but the absence of these words does not mean that a
statement is not forward-looking.
The forward-looking statements contained in this Quarterly Report on Form
10-Q
are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future
developments affecting us will be those that we have anticipated. These
forward-looking statements involve a number of risks, uncertainties (some of
which are beyond our control) or other assumptions that may cause actual results
or performance to be materially different from those expressed or implied by
these forward-looking statements. These risks and uncertainties include, but are
not limited to, the following risks, uncertainties (some of which are beyond our
control) or other factors:

     •    we have no operating history and no revenues, and you have no basis on
          which to evaluate our ability to achieve our business objective;



  •   our ability to select an appropriate target business or businesses;



     •    our ability to complete a merger, share exchange, asset acquisition,
          share purchase, reorganization or similar business combination with one
          or more businesses (the "Business Combination");



     •    our expectations around the performance of a prospective target business
          or businesses;



     •    our success in retaining or recruiting, or changes required in, our
          officers, key employees or directors following our initial Business
          Combination;



     •    our officers and directors allocating their time to other businesses and
          potentially having conflicts of interest with our business or in
          approving our initial Business Combination;



     •    our potential ability to obtain additional financing to complete our
          initial Business Combination;



  •   our pool of prospective target businesses;



     •    our ability to consummate an initial Business Combination due to the
          uncertainty resulting from the recent
          COVID-19
          pandemic;



     •    the ability of our officers and directors to generate a number of
          potential Business Combination opportunities;



  •   our public securities' potential liquidity and trading;



     •    the use of proceeds not held in the trust account or available to us from
          interest income on the trust account balance;



  •   the trust account not being subject to claims of third parties;



  •   our financial performance following our initial public offering; and



     •    the other risks and uncertainties discussed herein and in "Item 1A. Risk
          Factors" and elsewhere in our annual report on Form
          10-K,
          filed with the SEC on March 19, 2021.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.



                                       17

--------------------------------------------------------------------------------

Overview


We are a blank check company incorporated in the Cayman Islands on August 26,
2020 for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar Business Combination with one or more
businesses that we have not yet selected. While we may pursue an acquisition
opportunity in any business, industry, sector or geographical location, we
intend to focus on industries that complement our management team's background
and to capitalize on the ability of our management team to identify and acquire
a business, focusing on the healthcare or healthcare related industries. In
particular, we will pursue investments, primarily based in North America and
Europe and selectively in other geographies, including Asia and emerging
markets, in biopharmaceutical, specialty pharmaceutical, medical device,
diagnostics and enabling life science technology companies. We may pursue a
transaction in which our shareholders immediately prior to the completion of our
initial Business Combination would collectively own a minority interest in the
post-business combination company.
Our sponsor is BCLS Acquisition Holdings, LP, a Cayman Islands exempted limited
partnership (the "Sponsor"). The registration statement for our initial public
offering (the "Initial Public Offering") was declared effective on October 21,
2020 (the "IPO Registration Statement"). On October 26, 2020, we consummated our
Initial Public Offering of 14,375,000 Class A ordinary shares (the "Public
Shares"), including 1,875,000 Public Shares as a result of the underwriters'
full exercise of their over-allotment option, at an offering price of $10.00 per
Public Share, generating gross proceeds of approximately $143.8 million. We
incurred total offering costs of approximately $8.5 million (inclusive of
approximately $5.0 million in deferred underwriting fees).
Simultaneously with the closing of the Initial Public Offering, we consummated
the private placement ("Private Placement") of 487,500 Class A ordinary shares
(the "Private Placement Shares"), at a price of $10.00 per Private Placement
Share to the Sponsor, generating gross proceeds of approximately $4.9 million.
Upon the closing of the Initial Public Offering and the Private Placement,
approximately $143.8 million ($10.00 per Public Share) of the net proceeds of
the Initial Public Offering and certain of the proceeds of the Private Placement
were placed in a trust account (the "Trust Account"), located in the United
States with Continental Stock Transfer & Trust Company acting as trustee, and
are invested only in U.S. "government securities" within the meaning set forth
in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the
"Investment Company Act"), having a maturity of 185 days or less or in money
market funds meeting certain conditions under Rule
2a-7
promulgated under the Investment Company Act which invest only in direct U.S.
government treasury obligations, until the earlier of: (i) the completion of a
Business Combination, and then only in connection with those Class A ordinary
shares that the holders of Public Shares (the "Public Shareholders") properly
elected to redeem, subject to certain limitations described in the IPO
Registration Statement, (ii) the redemption of any Public Shares properly
tendered in connection with a shareholder vote to amend our amended and restated
memorandum and articles of association (the "Amended and Restated Memorandum and
Articles of Association") (A) to modify the substance or timing of our
obligation to provide holders of Class A ordinary shares the right to have their
shares redeemed in connection with our initial Business Combination or to redeem
100% of our Public Shares if we do not complete our initial Business Combination
within 24 months from the closing of our Initial Public Offering, or October 26,
2022 (the "Combination Period"), or (B) with respect to any other provision
relating to the rights of holders of Class A ordinary shares, and (iii) the
redemption of the Class A ordinary shares if we have not consummated our
Business Combination within the Combination Period, subject to applicable law.
The remaining net proceeds (not held in the Trust Account) may be used to pay
for business, legal and accounting due diligence on prospective acquisitions and
continuing general and administrative expenses. We may use the interest income
generated by the assets in the Trust Account to pay for taxes that were paid by
us or are payable by us and, in case we do not complete our initial Business
Combination within the Combination Period, $100,000 of the interest income may
be used to pay dissolution expenses.
Our management has broad discretion with respect to the specific application of
the net proceeds of the Initial Public Offering and the sale of Private
Placement Shares, although substantially all of the net proceeds are intended to
be applied generally toward consummating a Business Combination.

                                       18

--------------------------------------------------------------------------------

If we have not completed a Business Combination within the Combination Period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders' rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. We intend to effectuate our initial Business Combination using cash from the proceeds of our Initial Public Offering and the sale of the Private Placement Shares, our shares, debt or a combination of cash, equity and debt. The issuance of additional shares in a Business Combination:



     •    may significantly dilute the equity interest of investors in our Initial
          Public Offering, which dilution would increase if the anti-dilution
          provisions in the Class B ordinary shares resulted in the issuance of
          Class A ordinary shares on a greater than
          one-to-one
          basis upon conversion of the Class B ordinary shares;



     •    may subordinate the rights of holders of Class A ordinary shares if
          preference shares are issued with rights senior to those afforded our
          Class A ordinary shares;



     •    could cause a change in control if a substantial number of our Class A
          ordinary shares are issued, which may affect, among other things, our
          ability to use our net operating loss carry forwards, if any, and could
          result in the resignation or removal of our present officers and
          directors;



     •    may have the effect of delaying or preventing a change of control of us
          by diluting the share ownership or voting rights of a person seeking to
          obtain control of us; and



     •    may adversely affect prevailing market prices for our Class A ordinary
          shares.


Similarly, if we issue debt or otherwise incur significant debt, it could result
in:

     •    default and foreclosure on our assets if our operating revenues after an
          initial Business Combination are insufficient to repay our debt
          obligations;



     •    acceleration of our obligations to repay the indebtedness even if we make
          all principal and interest payments when due if we breach certain
          covenants that require the maintenance of certain financial ratios or
          reserves without a waiver or renegotiation of that covenant;



     •    our immediate payment of all principal and accrued interest, if any, if
          the debt is payable on demand;



     •    our inability to obtain necessary additional financing if the debt
          contains covenants restricting our ability to obtain such financing while
          the debt is outstanding;



  •   our inability to pay dividends on our Class A ordinary shares;



     •    using a substantial portion of our cash flow to pay principal and
          interest on our debt, which will reduce the funds available for dividends
          on our Class A ordinary shares if declared, expenses, capital
          expenditures, acquisitions and other general corporate purposes;



     •    limitations on our flexibility in planning for and reacting to changes in
          our business and in the industry in which we operate;



     •    increased vulnerability to adverse changes in general economic, industry
          and competitive conditions and adverse changes in government regulation;
          and



     •    limitations on our ability to borrow additional amounts for expenses,
          capital expenditures, acquisitions, debt service requirements, execution
          of our strategy and other purposes and other disadvantages compared to
          our competitors who have less debt.

Results of Operations Our entire activity from August 26, 2020 up to October 26, 2020 was in preparation for an Initial Public Offering, and since our Initial Public Offering, our activity has been limited to the search for a prospective initial Business Combination. We will not generate any operating revenues until the closing and completion of our initial Business Combination, at the earliest.



                                       19

--------------------------------------------------------------------------------


For the three months ended September 30, 2021, we had a net loss of
approximately $191,000, which consisted of approximately $163,000 of general and
administrative expenses, $30,000 in general and administrative expenses-related
party, partly offset by approximately $2,000 of net gain from investments held
in the trust account.
For the nine months ended September 30, 2021, we had a net loss of approximately
$598,000, which consisted of approximately $514,000 of general and
administrative expenses, $90,000 in general and administrative expenses-related
party, partly offset by approximately $4,000 of net gain from investments held
in the trust account.
Liquidity and
Going Concern
As of September 30, 2021, we had approximately $745,000 in our operating bank
account, and working capital of approximately $671,000.
Our liquidity needs to date have been satisfied through a payment of $25,000 by
our Sponsor to cover certain expenses in exchange for the issuance of the
founder shares, a loan of approximately $46,000 from our Sponsor pursuant to a
promissory note, dated August 31, 2020 (the "Note"), and the proceeds from the
consummation of the Private Placement not held in the trust account. We repaid
the Note in full on October 29, 2020. In addition, in order to finance
transaction costs in connection with a Business Combination, the Sponsor or an
affiliate of the Sponsor, or certain of our officers and directors may, but is
not obligated to, provide us with working capital loans. To date, there are no
working capital loans outstanding.
In connection with the Company's assessment of going concern considerations in
accordance with FASB Accounting Standards Update ("ASU")
2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," management has determined that the mandatory liquidation and
subsequent dissolution raises substantial doubt about the Company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
within a year. The financial statements do not include any adjustment that might
be necessary if the Company is unable to continue as a going concern.
Management continues to evaluate the impact of the
COVID-19
pandemic on the industry and has concluded that the specific impact is not
readily determinable as of the date of these unaudited financial statements. The
unaudited financial statements do not include any adjustments that might result
from the outcome of this uncertainty.
Other Contractual Obligations
Administrative Support Agreement
Commencing on the date that the IPO Registration Statement was declared
effective we agreed to pay our Sponsor a total of $10,000 per month for office
space, utilities, secretarial and administrative support services. Upon
completion of the initial Business Combination or the Company's liquidation, we
will cease paying these monthly fees. We incurred $30,000 and $90,000 in such
expenses included as "Administrative fee-related party" on the accompanying
unaudited condensed statements of operations for the three and nine months ended
September 30, 2021, respectively.
Registration and Shareholder Rights
The holders of Founder Shares, Private Placement Shares, and securities that may
be issued upon conversion of Working Capital Loans, if any, are entitled to
registration rights pursuant to a registration and shareholder rights agreement.
The holders of these securities are entitled to make up to three demands,
excluding short form demands, that we register such securities. In addition, the
holders have certain "piggy-back" registration rights with respect to
registration statements filed subsequent to our completion of a Business
Combination. However, the registration and shareholder rights agreement provides
that we will not permit any registration statement filed under the Securities
Act to become effective until termination of the applicable
lock-up
period, which occurs (i) in the case of the Founder Shares, in accordance with
the letter agreement our Initial Shareholders entered into and (ii) in the case
of the Private Placement Shares, 30 days after the completion of our Business
Combination. The Company will bear the expenses incurred in connection with the
filing of any such registration statements.

                                       20

--------------------------------------------------------------------------------


Underwriting Agreement
We granted the underwriters a
45-day
option from the date of the final prospectus relating to the Initial Public
Offering to purchase up to 1,875,000 additional Public Shares to cover
over-allotments at the Initial Public Offering price less the underwriting
discounts and commissions. The underwriters fully exercised the over-allotment
option on October 26, 2020.
The underwriters were paid a cash underwriting discount of $0.20 per Public
Share, or $2.9 million in the aggregate, which was paid upon the closing of the
Initial Public Offering. In addition, $0.35 per Public Share, or approximately
$5.0 million in the aggregate, will be payable to the underwriters for deferred
underwriting commissions. The deferred fee will become payable to the
underwriters from the amounts held in the Trust Account solely in the event that
we complete a Business Combination, subject to the terms of the underwriting
agreement.
Critical Accounting Policies and Use of Estimates
This management's discussion and analysis of our financial condition and results
of operations is based on our financial statements, which have been prepared in
accordance with U.S. GAAP. The preparation of these financial statements
requires us to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses and the disclosure of contingent
assets and liabilities in our financial statements. On an ongoing basis, we
evaluate our estimates and judgments, including those related to fair value of
financial instruments and accrued expenses. We base our estimates on historical
experience, known trends and events and various other factors that we believe to
be reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these
estimates under different assumptions or conditions. We have identified the
following as our critical accounting policies:
Investments Held in the Trust Account
Our portfolio of investments is comprised of U.S. government securities, within
the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a
maturity of 185 days or less, or investments in money market funds that invest
in U.S. government securities and generally have a readily determinable fair
value, or a combination thereof. When our investments held in the Trust Account
are comprised of U.S. government securities, the investments are classified as
trading securities. When our investments held in the Trust Account are comprised
of money market funds, the investments are recognized at fair value. Trading
securities and investments in money market funds are presented on the balance
sheets at fair value at the end of each reporting period. Gains and losses
resulting from the change in fair value of these securities is included in net
gain from investments held in the Trust Account in the accompanying unaudited
condensed statement of operations. The estimated fair values of investments held
in the Trust Account are determined using available market information.
Class A ordinary shares subject to possible redemption
We account for our Class A ordinary shares subject to possible redemption in
accordance with the guidance in ASC Topic 480 "Distinguishing Liabilities from
Equity." Class A ordinary shares subject to mandatory redemption (if any) are
classified as liability instruments and are measured at fair value.
Conditionally redeemable Class A ordinary shares (including Class A ordinary
shares that feature redemption rights that are either within the control of the
holder or subject to redemption upon the occurrence of uncertain events not
solely within our control) are classified as temporary equity. At all other
times, Class A ordinary shares are classified as shareholders' equity. As part
of the Private Placement, the Company issued 487,500 Private Placement Shares to
the Sponsor. These Private Placement Shares will not be transferable, assignable
or salable until 30 days after the completion of our initial Business
Combination. They are also
non-redeemable
and are presented as permanent equity in our condensed balance sheet. Our
Class A ordinary shares feature certain redemption rights that are considered to
be outside of our control and subject to the occurrence of uncertain future
events. Accordingly, 14,375,000 Class A ordinary shares that are subject to
possible redemption are presented at redemption value as temporary equity,
outside of the shareholders' equity section of our condensed balance sheet.

                                       21

--------------------------------------------------------------------------------


Effective with the closing of the Initial Public Offering, we recognized the
accretion from initial book value to redemption amount, which resulted in
charges against additional
paid-in
capital (to the extent available) and accumulated deficit.
Net Income (loss) Per Ordinary Share
We comply with accounting and disclosure requirements of FASB ASC Topic 260,
"Earnings Per Share." We have two classes of shares, which are referred to as
Class A ordinary shares and Class B ordinary shares. Income and losses are
shared pro rata between the two classes of shares. Net income (loss) per
ordinary share is calculated by dividing the net income (loss) by the weighted
average number of ordinary shares outstanding for the respective period.
Accretion associated with the Class A ordinary shares is excluded from earnings
per share as the redemption value approximates fair value.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU
No. 2020-06,
Debt-Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity's Own Equity
("ASU
2020-06"),
which simplifies accounting for convertible instruments by removing major
separation models required under current GAAP. The ASU also removes certain
settlement conditions that are required for equity-linked contracts to qualify
for the derivative scope exception, and it simplifies the diluted earnings per
share calculation in certain areas. We adopted ASU
2020-06
on January 1, 2021. Adoption of the ASU did not impact our financial position,
results of operations or cash flows.
Management does not believe that any other recently issued, but not yet
effective, accounting standards if currently adopted, would have a material
effect on the accompanying unaudited condensed financial statements.
Off-Balance
Sheet Arrangements
As of September 30, 2021, we did not have any
off-balance
sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation
S-K.
JOBS Act
On April 5, 2012, the Jumpstart Our Business Startups Act of 2012 (the "JOBS
Act") was signed into law. The JOBS Act contains provisions that, among other
things, relax certain reporting requirements for qualifying public companies. We
qualify as an "emerging growth company" and under the JOBS Act are allowed to
comply with new or revised accounting pronouncements based on the effective date
for private (not publicly traded) companies. We are electing to delay the
adoption of new or revised accounting standards, and as a result, we may not
comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for
non-emerging
growth companies. As such, our financial statements may not be comparable to
companies that comply with public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the
other reduced reporting requirements provided by the JOBS Act. Subject to
certain conditions set forth in the JOBS Act, if, as an "emerging growth
company," we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor's attestation report on our system of
internal control over financial reporting pursuant to Section 404 of the
Sarbanes-Oxley Act of 2002, (ii) provide all of the compensation disclosure that
may be required of
non-emerging
growth public companies under the Dodd-Frank Wall Street Reform and Consumer
Protection Act, (iii) comply with any requirement that may be adopted by the
PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's
report providing additional information about the audit and the financial
statements (auditor discussion and analysis) and (iv) disclose certain executive
compensation related items such as the correlation between executive
compensation and performance and comparisons of executive compensation to median
employee compensation. These exemptions will apply for a period of five years
following the completion of our Initial Public Offering or until we are no
longer an "emerging growth company," whichever is earlier.

                                       22

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses